Study: NCT00518180

Adverse event: Cushing's syndrome
Serious: yes
Organ System: Endocrine disorders
Frequency: 1 affected / 540 at risk

Adverse event: Pituitary tumour benign
Serious: yes
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Frequency: 1 affected / 540 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 124 affected / 540 at risk

Adverse event: Chills
Serious: no
Organ System: General disorders
Frequency: 100 affected / 540 at risk

Adverse event: INJECTION SITE ERYTHEMA HPV
Serious: no
Organ System: General disorders
Frequency: 134 affected / 540 at risk

Adverse event: INJECTION SITE INDURATION HPV
Serious: no
Organ System: General disorders
Frequency: 119 affected / 540 at risk

Adverse event: INJECTION SITE PAIN HPV
Serious: no
Organ System: General disorders
Frequency: 387 affected / 540 at risk

Adverse event: Malaise
Serious: no
Organ System: General disorders
Frequency: 171 affected / 540 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 62 affected / 540 at risk

Adverse event: Arthralgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 119 affected / 540 at risk

Adverse event: Myalgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 178 affected / 540 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 260 affected / 540 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 31 affected / 540 at risk

Adverse event: INJECTION SITE ERYTHEMA MENVEO
Serious: no
Organ System: General disorders
Frequency: 69 affected / 540 at risk

Adverse event: INJECTION SITE ERYTHEMA Tdap
Serious: no
Organ System: General disorders
Frequency: 78 affected / 540 at risk

Adverse event: INJECTION SITE INDURATION MENVEO
Serious: no
Organ System: General disorders
Frequency: 68 affected / 540 at risk

Adverse event: INJECTION SITE INDURATION Tdap
Serious: no
Organ System: General disorders
Frequency: 90 affected / 540 at risk

Adverse event: INJECTION SITE PAIN MENVEO
Serious: no
Organ System: General disorders
Frequency: 264 affected / 540 at risk

Adverse event: INJECTION SITE PAIN Tdap
Serious: no
Organ System: General disorders
Frequency: 368 affected / 540 at risk

Adverse event: Bezoar
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 541 at risk

Adverse event: Appendicitis
Serious: yes
Organ System: Infections and infestations
Frequency: 2 affected / 541 at risk

Adverse event: Abortion spontaneous
Serious: yes
Organ System: Pregnancy, puerperium and perinatal conditions
Frequency: 1 affected / 541 at risk

Adverse event: Haemorrhagic ovarian cyst
Serious: yes
Organ System: Reproductive system and breast disorders
Frequency: 1 affected / 541 at risk

Adverse event: Testicular torsion
Serious: yes
Organ System: Reproductive system and breast disorders
Frequency: 1 affected / 541 at risk

Adverse event: Behcet's syndrome
Serious: yes
Organ System: Vascular disorders
Frequency: 1 affected / 541 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 133 affected / 541 at risk

Adverse event: Chills
Serious: no
Organ System: General disorders
Frequency: 117 affected / 541 at risk

Adverse event: INJECTION SITE ERYTHEMA HPV
Serious: no
Organ System: General disorders
Frequency: 105 affected / 541 at risk

Adverse event: INJECTION SITE INDURATION HPV
Serious: no
Organ System: General disorders
Frequency: 81 affected / 541 at risk

Adverse event: INJECTION SITE PAIN HPV
Serious: no
Organ System: General disorders
Frequency: 320 affected / 541 at risk

Adverse event: Malaise
Serious: no
Organ System: General disorders
Frequency: 209 affected / 541 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 88 affected / 541 at risk

Adverse event: Arthralgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 132 affected / 541 at risk

Adverse event: Myalgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 187 affected / 541 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 284 affected / 541 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 47 affected / 541 at risk

Adverse event: INJECTION SITE ERYTHEMA MENVEO
Serious: no
Organ System: General disorders
Frequency: 66 affected / 541 at risk

Adverse event: INJECTION SITE ERYTHEMA Tdap
Serious: no
Organ System: General disorders
Frequency: 38 affected / 541 at risk

Adverse event: INJECTION SITE INDURATION MENVEO
Serious: no
Organ System: General disorders
Frequency: 70 affected / 541 at risk

Adverse event: INJECTION SITE INDURATION Tdap
Serious: no
Organ System: General disorders
Frequency: 64 affected / 541 at risk

Adverse event: INJECTION SITE PAIN MENVEO
Serious: no
Organ System: General disorders
Frequency: 246 affected / 541 at risk

Adverse event: INJECTION SITE PAIN Tdap
Serious: no
Organ System: General disorders
Frequency: 310 affected / 541 at risk

Adverse event: Road traffic accident
Serious: yes
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 539 at risk

Adverse event: Abortion spontaneous
Serious: yes
Organ System: Pregnancy, puerperium and perinatal conditions
Frequency: 1 affected / 539 at risk

Adverse event: Hydronephrosis
Serious: yes
Organ System: Renal and urinary disorders
Frequency: 1 affected / 539 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 142 affected / 539 at risk

Adverse event: Chills
Serious: no
Organ System: General disorders
Frequency: 130 affected / 539 at risk

Adverse event: INJECTION SITE ERYTHEMA HPV
Serious: no
Organ System: General disorders
Frequency: 101 affected / 539 at risk

Adverse event: INJECTION SITE INDURATION HPV
Serious: no
Organ System: General disorders
Frequency: 85 affected / 539 at risk

Adverse event: INJECTION SITE PAIN HPV
Serious: no
Organ System: General disorders
Frequency: 313 affected / 539 at risk

Adverse event: Malaise
Serious: no
Organ System: General disorders
Frequency: 194 affected / 539 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 84 affected / 539 at risk

Adverse event: Arthralgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 131 affected / 539 at risk

Adverse event: Myalgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 200 affected / 539 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 278 affected / 539 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 42 affected / 539 at risk

Adverse event: INJECTION SITE ERYTHEMA MENVEO
Serious: no
Organ System: General disorders
Frequency: 65 affected / 539 at risk

Adverse event: INJECTION SITE ERYTHEMA Tdap
Serious: no
Organ System: General disorders
Frequency: 72 affected / 539 at risk

Adverse event: INJECTION SITE INDURATION MENVEO
Serious: no
Organ System: General disorders
Frequency: 65 affected / 539 at risk

Adverse event: INJECTION SITE INDURATION Tdap
Serious: no
Organ System: General disorders
Frequency: 110 affected / 539 at risk

Adverse event: INJECTION SITE PAIN MENVEO
Serious: no
Organ System: General disorders
Frequency: 239 affected / 539 at risk

Adverse event: INJECTION SITE PAIN Tdap
Serious: no
Organ System: General disorders
Frequency: 383 affected / 539 at risk